Omeprazole (OM) v ranitidine for ulcers associated with long term non-steroidal anti-inflammatory drug use1-2-150
| Outcomes | OM 20 mg/day | OM 40 mg/day | Ranitidine 300 mg/day | RBI (95% CI) | NNT (CI) |
| Healing at 8 weeks | 80% | 63% | 27% (12 to 46) | 6 (4 to 13) | |
| Healing at 8 weeks | 79% | 63% | 25% (10 to 44) | 7 (4 to 16) | |
| Remission at 6 months | 72% | 59% | 22% (6 to 40) | 8 (5 to 27) |
-
↵1-2-150 RBI = proportional increase in rates of good outcomes between groups; NNT = number of patients who must receive omeprazole to achieve 1 additional good outcome.
-
Note: the material presented in the table was not in the orginal article on which the commentary is based.
